Ayala Pharmaceuticals, Inc.

13D and 13G Filings

13D/G filings
13G on 1 security
Location
Monmouth Junction, NJ
CIK
0001100397
Alternate names
Advaxis, Inc.
Form D filings
14 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
OS Therapies Incorporated 13G
OSTX · 68764Y207
10.0% 4/16/2025
Event 4/9/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.